comparemela.com

Latest Breaking News On - Ophthalmic - Page 6 : comparemela.com

Novaliq Announces Presentation of New Scientific Data on CyclASol 0 1% (Cyclosporine Ophthalmic Solution) at the American Society of Cataract and Refractive Surgery Annual Meeting

Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, today announced the presentation of new data on the investigational

United kingdomUnited statesBaden wübergSan diegoChristian roeskyDavid wirtaNovaliq gmbAmerican society of cataractGmbh coNovaliq incDrug administrationHealth sciencesAmerican societyRefractive surgeryPrescription drug user fee actTerm safety

Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Society of Cataract and Refractive Surgery Annual Meeting

Glaukos Corporation , an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today. | May 1, 2023

United statesSan diegoTransepithelial crossAshraf armia balamounWilliamb trattlerJohnp berdahlInterno canaloplastyMiltos balidisMiltiadis balidisXiongfei liuPhilip dockeryKennetha beckmanBrendang croninIkek ahmedMitchellc shultzJulia yu

Outlook Therapeutics® to Present at the H C Wainwright BioConnect Investor Conference

ISELIN, N.J., April 27, 2023 Outlook Therapeutics, Inc. , a biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in. | April 27, 2023

United statesUnited kingdomJenene thomasHarriet ullmanRuss trenaryOutlook therapeutics incGlobenewswire incLavoie health scienceChief executive officerExecutive directorCommercial excellenceOutlook therapeuticsOutlook therapeuticNc stock exchangePress releaseSe otlk us69012t2069

Early Anti-VEGF Isn t Worth Cost in Diabetic Retinopathy

A drug tested on patients with nonproliferative diabetic retinopathy did not improve vision outcomes.

United statesSamsung bioepisEli lillyNimesh patelLee jampolMidwest eye institute in indianapolisJaeb centerRetina networkHealth researchNorthwestern university feinberg school of medicineRegeneron pharmaceuticalsAssociation for researchBoehringer ingelheimRaj maturiMidwest eye instituteMedscape medical

Nova Eye Medical Announces U S Market Clearance of the iTrack™ Advance Canaloplasty Device

Nova Eye Medical Limited , a medical technology company committed to advanced ophthalmic treatment technologies and devices, today announces that it has been granted U.S. Food and Drug. | April 12, 2023

United statesSan diegoSouth australiaNew zealandJamesp lutonMark conformitMahmouda khaimiTom spurlingAmerican society of cataractNova eye medical limitedNova eye medicalDean mcgee eye instituteOphthalmology at dean mcgee eye instituteUniversity of oklahomaDrug administrationClinical professor

vimarsana © 2020. All Rights Reserved.